Docket: 00N-1652 - Requirements for Submission of Labeling of Human Prescription Drugs & Biologics in Electronic Format Comment Number: EC -1
Accepted - Volume 1
Ms. Barbara Lavery
Comments for FDA General
1. General Comments
With a client list of over 35 life science companies how can we connect with the FDA to show how our online communications tools may help clients with e-submission of labeling and marketing materials for drugs.